PTSM: Pharmaceutical Technology Sourcing and Management
BASF’s new multi-product amines plant in Ludwigshafen, Germany meets growing demand for amines in various applications, including pharmaceuticals.
BASF started up a world-scale plant for the production of specialty amines in Ludwigshafen, Germany, the company announced in a Nov. 5, 2015 press release. The multi-product plant can manufacture approximately 12,000 metric tons per year of a product range of about 15 amines for different applications, including pharmaceuticals. With the new facility, BASF expands its global production network for amines with plants in Ludwigshafen and Schwarzheide in Germany; Antwerp, Belgium; Geismar, North America; and Nanjing, China.
“With the new plant, we are responding to our customers’ growing demand for specialty amines, particularly in Europe,” said Stefan Blank, president, BASF Intermediates division.
The flexible plant can also be used for the production of new specialty amines. BASF offers approximately 200 different amines. In addition to alkylamines, alkanolamines, and alkoxyalkylamines, the company also offers heterocyclic and aromatic amines as well as specialty amines. The range is completed by an expanding portfolio of chiral amines with high optical and chemical purity.
Source: BASF
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.